N
INFU icon

Natixis’s InfuSystem Holdings INFU Stock Holding History

Natixis’s Portfolio INFU Stock Details INFU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,316
Closed -$85K – 1216
2022
Q3 		$85K Buy
+11,316
New +$94.8K ﹤0.01% 998
2014
Q2 		– Sell
-26,100
Closed -$73K – 489
2014
Q1 		$73K Buy
+26,100
New +$67.2K ﹤0.01% 470

Other funds holding INFU

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
MIM
Meros Investment Management Dallas, Texas $231M AUM 35.94% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Natixis's INFU Position: Q4 2022 in Review

Natixis sold out of InfuSystem Holdings (INFU) in Q4 2022, closing a stake of 11,316 shares — an estimated $85K sold.

Natixis first reported a position in INFU in Q1 2014 and held it in 2 quarters. The position peaked at $85K in Q3 2022. 63 funds tracked by Wall St. Rank hold INFU as of Q4 2022.

  • Natixis reported no remaining InfuSystem Holdings position as of Q4 2022 after selling out during the quarter.
  • Natixis sold 11,316 InfuSystem Holdings shares in Q4 2022, an estimated $85K.
  • Natixis first reported a position in InfuSystem Holdings in Q1 2014 and held it in 2 quarters.
  • Natixis's InfuSystem Holdings position peaked at $85K in Q3 2022.
  • 63 funds tracked by Wall St. Rank held InfuSystem Holdings as of Q4 2022.

Based on Natixis's 13F filing for Q4 2022, filed 13 Feb 2023.